The Latest Breaking News from Vaccine

Pfizer Inc plans to sell its entire portfolio of brand-name drugs at cost in as many as 45 lower-income countries, including Cambodia and Laos, one of the most comprehensive and ambitious drug-access programmes ever announced by a large pharmaceutical manufacturer.

Simply fab news for hot girl winter.

An extra 1.5 million people are now eligible to receive a fourth COVID-19 vaccine, or second booster.

The nation's vaccine advisory group recommends another 1.5 million Australians get a fourth COVID-19 booster shot coming into the winter months.

So far this year, the Northern Territory has recorded 968 cases of influenza, compared to just 76 cases in all of 2021.

SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ:HLVX) shares with an Outperform rating and a $30 price target.  The analyst believes the company’s potentially first-in-class infant norovirus vaccine HIL214 represents a uniquely de-risked opportunity.  It estimates $625 million in risk-adjusted infant HIL214 sales in 2030E ($1 billion unadjusted).  The outlook is supported by…

As cases of monkeypox continue to rise, Moderna Inc (NASDAQ: MRNA) is probably working on its platform towards finding a vaccine shot against the disease.

A doctor heading a World Health Organization group says the outbreak in developed countries is ‘a random event’ possibly explained by risky sexual behavior at two raves in Europe.

Hospitals in Greater Manchester are understood to be preparing for monkeypox